Xylem Inc (XYL) Shares Sold by DNB Asset Management AS

Share on StockTwits

DNB Asset Management AS lowered its stake in shares of Xylem Inc (NYSE:XYL) by 2.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 35,444 shares of the industrial products company’s stock after selling 1,046 shares during the period. DNB Asset Management AS’s holdings in Xylem were worth $2,801,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Thrivent Financial for Lutherans grew its stake in Xylem by 1.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 7,864 shares of the industrial products company’s stock valued at $525,000 after buying an additional 138 shares in the last quarter. Cascade Investment Advisors Inc. grew its stake in Xylem by 25.0% in the 4th quarter. Cascade Investment Advisors Inc. now owns 1,000 shares of the industrial products company’s stock valued at $67,000 after buying an additional 200 shares in the last quarter. Independent Investors Inc. grew its stake in Xylem by 2.5% in the 4th quarter. Independent Investors Inc. now owns 9,500 shares of the industrial products company’s stock valued at $633,000 after buying an additional 230 shares in the last quarter. Mercer Capital Advisers Inc. grew its stake in Xylem by 33.3% in the 4th quarter. Mercer Capital Advisers Inc. now owns 1,000 shares of the industrial products company’s stock valued at $67,000 after buying an additional 250 shares in the last quarter. Finally, Macquarie Group Ltd. grew its stake in Xylem by 9.1% in the 4th quarter. Macquarie Group Ltd. now owns 3,104 shares of the industrial products company’s stock valued at $207,000 after buying an additional 260 shares in the last quarter. Institutional investors own 87.11% of the company’s stock.

In other news, insider Tomas Brannemo sold 559 shares of Xylem stock in a transaction on Thursday, February 21st. The shares were sold at an average price of $74.44, for a total transaction of $41,611.96. Following the completion of the sale, the insider now directly owns 10,568 shares of the company’s stock, valued at approximately $786,681.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kenneth Napolitano sold 35,526 shares of Xylem stock in a transaction on Monday, February 4th. The stock was sold at an average price of $70.17, for a total transaction of $2,492,859.42. The disclosure for this sale can be found here. Over the last three months, insiders sold 80,195 shares of company stock valued at $6,000,933. Insiders own 0.81% of the company’s stock.

Shares of NYSE:XYL opened at $81.87 on Tuesday. The company has a quick ratio of 1.08, a current ratio of 1.51 and a debt-to-equity ratio of 0.74. Xylem Inc has a one year low of $60.65 and a one year high of $82.64. The firm has a market capitalization of $14.66 billion, a price-to-earnings ratio of 28.43, a PEG ratio of 1.39 and a beta of 1.14.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, January 31st. The industrial products company reported $0.88 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.88. Xylem had a net margin of 10.54% and a return on equity of 19.89%. The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.36 billion. On average, equities analysts expect that Xylem Inc will post 3.32 earnings per share for the current fiscal year.

A number of research analysts recently weighed in on the stock. Janney Montgomery Scott lowered shares of Xylem from a “buy” rating to a “neutral” rating in a research note on Friday, March 29th. Zacks Investment Research lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, February 9th. Oppenheimer set a $80.00 price objective on shares of Xylem and gave the company a “buy” rating in a research note on Monday, February 4th. Stifel Nicolaus upgraded shares of Xylem from a “hold” rating to a “buy” rating and lifted their price objective for the company from $72.00 to $75.00 in a research note on Wednesday, December 19th. Finally, ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Monday, February 4th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $78.36.

TRADEMARK VIOLATION NOTICE: “Xylem Inc (XYL) Shares Sold by DNB Asset Management AS” was originally published by Macon Daily and is the sole property of of Macon Daily. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://macondaily.com/2019/04/16/xylem-inc-xyl-shares-sold-by-dnb-asset-management-as.html.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Further Reading: Marijuana Stocks

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.